SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001005286-23-000056
Filing Date
2023-03-16
Accepted
2023-03-16 16:08:28
Documents
71
Period of Report
2022-08-28

Document Format Files

Seq Description Document Type Size
1 10-Q/A lndc-20220828.htm   iXBRL 10-Q/A 1318010
2 EX-31.1 lndc-20220828xexx3111.htm EX-31.1 10249
3 EX-31.2 lndc-20220828xexx3121.htm EX-31.2 10689
4 EX-32.1 lndc-20220828xexx3211.htm EX-32.1 5815
5 EX-32.2 lndc-20220828xexx3221.htm EX-32.2 5923
  Complete submission text file 0001005286-23-000056.txt   8019418

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20220828.xsd EX-101.SCH 44066
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lndc-20220828_cal.xml EX-101.CAL 72199
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lndc-20220828_def.xml EX-101.DEF 322626
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20220828_lab.xml EX-101.LAB 599564
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20220828_pre.xml EX-101.PRE 461893
65 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20220828_htm.xml XML 1334168
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 10-Q/A | Act: 34 | File No.: 000-27446 | Film No.: 23738826
SIC: 2834 Pharmaceutical Preparations